Security Snapshot

Boundless Bio, Inc. - Common Stock, par value $0.0001 per share (BOLD) Institutional Ownership

CUSIP: 10170A100

13F Institutional Holders and Ownership History from Q1 2024 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

36

Shares (Excl. Options)

8,485,823

Price

$1.10

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-295,115
Value change
-$347,924
Number of holders
36
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
22,366,850
SEC-reported price per share
$1.63
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • BOLD - Boundless Bio, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 10170A100.
  • 36 institutions reported positions in Q1 2026.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 35 to 36 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $10,536,019 to $9,333,021.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 36 institutions filings for Q1 2026.

Open SEC evidence

Security key

10170A100

Latest holder period

Q1 2026

13F holders

36

13D/G owners

2

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
2
Security
BOLD
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 12% $3,086,625 2,684,022 FMR LLC 31 Dec 2025
CITADEL ADVISORS LLC 6.4% $1,763,067 1,433,388 Kenneth Griffin 26 Nov 2025

As of 31 Mar 2026, 36 institutional investors reported holding 8,485,823 shares of Boundless Bio, Inc. - Common Stock, par value $0.0001 per share (BOLD). This represents 38% of the company’s total 22,366,850 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
38%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FMR LLC 12% 2,695,455 +0.43% 0% $2,965,000
CITADEL ADVISORS LLC 6% 1,342,131 -0.87% 0% $1,476,344
SECTORAL ASSET MANAGEMENT INC 3% 678,574 0% 0.62% $746,431
Stonepine Capital Management, LLC 2.7% 597,682 -16% 0.58% $657,450
VANGUARD CAPITAL MANAGEMENT LLC 2.7% 597,192 0% 0% $656,911
WELLINGTON MANAGEMENT GROUP LLP 2.5% 556,233 0% 0% $611,856
RENAISSANCE TECHNOLOGIES LLC 1.8% 399,000 +17% 0% $438,900
Alyeska Investment Group, L.P. 1.3% 300,000 0% 0% $330,000
RBF Capital, LLC 0.89% 200,000 0% 0.01% $220,000
Ensign Peak Advisors, Inc 0.84% 187,500 0% 0% $206,250
Sio Capital Management, LLC 0.73% 163,679 0% 0.03% $180,047
GEODE CAPITAL MANAGEMENT, LLC 0.57% 127,576 +36% 0% $140,333
MILLENNIUM MANAGEMENT LLC 0.45% 99,875 -26% 0% $109,862
GSA CAPITAL PARTNERS LLP 0.43% 96,824 +55% 0.01% $107,000
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 0.38% 85,792 -33% 0.01% $94,370
BlackRock, Inc. 0.32% 70,675 +5.4% 0% $77,743
VANGUARD FIDUCIARY TRUST CO 0.29% 65,136 0% 0% $71,650
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.23% 50,500 0% 0% $55,550
Walleye Capital LLC 0.18% 39,624 0% 0% $43,586
XTX Topco Ltd 0.16% 34,671 -12% 0% $38,138
Qube Research & Technologies Ltd 0.08% 17,492 -6.5% 0% $19,241
Squarepoint Ops LLC 0.07% 16,374 0% $18,011
STATE STREET CORP 0.07% 15,962 0% 0% $17,558
MORGAN STANLEY 0.06% 13,000 0% 0% $14,300
ACADIAN ASSET MANAGEMENT LLC 0.06% 12,610 0% 0% $12,000

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
9
Latest
Q1 2026
Rows shown
1-9 of 9
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 8,485,823 $9,333,021 -$347,924 $1.10 36
2025 Q4 8,780,936 $10,536,019 -$1,070,476 $1.20 35
2025 Q3 9,621,325 $11,833,310 -$174,692 $1.23 34
2025 Q2 9,787,223 $9,883,853 -$4,661,743 $1.01 42
2025 Q1 13,012,498 $19,647,091 -$249,812 $1.51 52
2024 Q4 12,962,230 $37,589,408 -$2,220,511 $2.90 53
2024 Q3 13,275,578 $46,065,519 -$1,783,862 $3.47 54
2024 Q2 13,842,210 $53,440,888 -$15,936,188 $3.87 47
2024 Q1 14,582,563 $208,788,470 +$208,607,723 $14.25 43
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .